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Background. The purpose of the study was to systematically compare calciﬁcation patterns
in plaques on computed tomography angiography (CTA) with plaque characteristics on
intravascular ultrasound with radiofrequency backscatter analysis (IVUS-VH).
Methods and Results. In total, 108 patients underwent CTA and IVUS-VH. On CTA,
calciﬁcation patterns in plaques were classiﬁed as non-calciﬁed, spotty or dense calciﬁcations.
Plaques with spotty calciﬁcations were differentiated into small spotty (<1 mm), intermediate
spotty (1-3 mm) and large spotty calciﬁcations (‡3 mm). Plaque characteristics deemed more
high-risk on IVUS-VH were deﬁned by % necrotic core (NC) and presence of thin cap ﬁbro-
atheroma (TCFA). Overall, 300 plaques were identiﬁed both on CTA and IVUS-VH. % NC
core was signiﬁcantly higher in plaques with small spotty calciﬁcations as compared to non-
calciﬁed plaques (20% vs 13%, P 5 .006). In addition, there was a trend for a higher % NC in
plaques with small spotty calciﬁcations than in plaques with intermediate spotty calciﬁcations
(20% vs 14%, P 5 .053). Plaques with small spotty calciﬁcations had the highest % TCFA as
compared to large spotty and dense calciﬁcations (31% vs 9% and 31% vs 6%, P < .05).
Conclusion. Plaques with small spotty calciﬁcations on CTA were related to plaque
characteristics deemed more high-risk on IVUS-VH. Therefore, CTA may be valuable in the
assessment of the vulnerable plaque. (J Nucl Cardiol 2011;18:893–903.)
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INTRODUCTION
Computed tomography angiography (CTA) is a
rapidly evolving technique that has the ability to non-
invasively and accurately detect signiﬁcant coronary
artery stenosis and coronary atherosclerotic plaque.
1-5 A
potentially interesting application of CTA would be the
identiﬁcation of patients or lesions that have an increased
likelihood of plaque rupture leading to acute coronary
events. Several previous studies have identiﬁed speciﬁc
plaque characteristics which are frequently observed
with CTA in patients presenting with acute coronary
syndrome (ACS).
6-8 Among these characteristics, a
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893spotty pattern of calciﬁcations has been related to the
presence of ACS.
6-8 Indeed, preliminary data with CTA
demonstrated that culprit lesions in patients with ACS
had a higher prevalence of smaller spotty calciﬁcations
than target lesions in patient with stable complaints.
9
Moreover, the presence of spotty calciﬁcations on CTA
were associated with a higher likelihood of developing
ACS.
8
More detailed information on plaque characteristics
can be obtained by intravascular ultrasound with radio-
frequency backscatter analysis (IVUS-VH).
10,11 This
technique was developed to improve grayscale intra-
vascular ultrasound tissue characterization and provide
detailed quantitative information on plaque composition
in vivo.
12,13 Additionally, the presence of thin cap
ﬁbroatheroma (TCFA) on IVUS-VH was demonstrated
to be independently predictive of major cardiovascular
events during follow-up.
14
However, the relation between calciﬁcation patterns
on CTA and plaque characteristics on IVUS-VH has not
been previously reported. Furthermore, in previous
studies, the deﬁnition of spotty calciﬁcation on CTA has
been variable. Indeed, deﬁnitions for spotty calciﬁcation
on CTA have ranged from presence of any calciﬁed
material embedded in non-calciﬁed plaque to a speciﬁc
threshold regarding the size of calciﬁcation. Subse-
quently, due to the inconsistency of deﬁnitions,
comparability of spotty calciﬁcations on CTA between
investigations is hampered. Therefore, the purpose of the
study was to perform a systematic evaluation of plaques
with different calciﬁcation patterns on CTA and relate
this to plaque characteristics on IVUS-VH.
METHODS
Patient Population and Study Protocol
A total of 108 patients were included in this evaluation
who underwent CTA prior to invasive coronary angiography
with IVUS-VH of 1 to 3 vessels, as part of clinical protocol.
For this retrospective evaluation, consecutive patients were
selected as part of an ongoing registry addressing the relative
merits of CTA in relation to other imaging techniques.
15
Patient with chest pain were referred for imaging for the non-
invasive evaluation of coronary artery disease (CAD),
according to clinical protocol. Thereafter, patients were
referred for invasive coronary angiography in combination
with IVUS-VH based on the patient’s clinical presentation and/
or imaging results to further evaluate the extent and severity of
CAD. During invasive coronary angiography, an experienced
interventional cardiologist decided whether IVUS studies
should be performed. Clinical history was evaluated between
the CTA examination and invasive coronary angiography to
ensure that neither acute coronary syndromes nor worsening of
angina occurred between examinations. Exclusion criteria for
CTA examination were: (i) (supra) ventricular arrhythmias, (ii)
renal failure (glomerular ﬁltration rate \30 mL/minute), (iii)
known allergy to iodine contrast material, (iv) severe claus-
trophobia, (v) pregnancy. Patient data were prospectively
collected in the departmental Cardiology Information System
(EPD-Vision
, Leiden University Medical Center, Leiden, the
Netherlands) and retrospectively analyzed. Our institutional
review board does not require its approval and written
informed consent for retrospective technical analysis of data,
as was the case for this study. In each patient, the presence of
risk factors for CAD and medication (use of aspirin, statins,
beta-blocking medication and angiotensin-converting enzyme
(ACE) inhibitors) were recorded.
CTA
Image acquisition. CTA examination was per-
formed using either a 64-row helical scanner (Aquilion 64,
Toshiba Medical Systems, Toshiba Medical Systems, Otaw-
ara, Japan) or a 320-row volumetric scanner (Aquilion ONE,
Toshiba Medical Systems, Otawara, Japan). If the patient’s
heart rate was C65 beats/minute and no contra-indications
existed, beta-blocking medication (metoprolol 50 or 100 mg,
single oral dose, 1 hour prior to examination) was adminis-
tered. Scan parameters for the 64-row contrast enhanced
scan were: 400 ms gantry rotation time, collimation of
64 9 0.5 mm, tube voltage of 100-135 kV and tube current of
250-350 mA, depending on body posture. Non-ionic contrast
material (Iomeron 400, Bracco, Milan, Italy or Ultravist 370,
Bayer Schering Pharma AG Berlin, Germany) was adminis-
tered with an amount of 80-110 mL followed by a saline ﬂush
with a ﬂow rate of 5 mL/second. Datasets were reconstructed
from the retrospectively gated raw data, the best phase was
reconstructed with an interval of 0.3 mm. Using a single test
slice reconstructed throughout the various phases of the heart
cycle, other suitable R-R intervals were examined for addi-
tional reconstructions. Concerning the 320-row contrast
enhanced scan; imaging was performed in a single volume
using prospective triggering with exposure interval depending
on the heart rate. If the heart rate was C65 beats/minute, the
phase window was set 65%-85% of R-R interval, if the heart
rate was stable and \60 beats/minute the phase window was
set at 70%-80% of R-R interval. Scan parameters were:
350 ms gantry rotation time, 320 9 0.5 mm collimation, 100-
135 kV tube voltage and a tube current of 400-580 mA,
depending on body mass index (BMI). Overall, 60-90 mL
contrast material (Iomeron 400, Bracco, Milan, Italy) was
administered with a rate of 5-6 mL/second followed by a
saline ﬂush. Data acquisition was performed during an
inspiratory breath hold of approximately 4-10 seconds. Sub-
sequently, images were reconstructed in the best phase of the
R-R interval and transferred to a remote workstation for post-
processing.
Image analysis. CTA datasets were evaluated using
dedicated software (Vitrea 2.0 or Vitrea FX 1.1 Vital images,
Minnetonka, MN, USA). Analysis was performed with the use
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slices and multiplanar reconstructions. One experienced
reader, blinded to the IVUS-VH results, evaluated the CTA
datasets. The coronary arteries were divided into 17 segments
according to the modiﬁed American Heart Association clas-
siﬁcation.
16 Each segment was evaluated for the presence of
any atherosclerotic plaque. Structures [1m m
2 within and/or
adjacent to the coronary artery lumen, which could be clearly
distinguished from the vessel lumen, were deﬁned as athero-
sclerotic plaque.
3
Calciﬁcation patterns in plaques on CTA were classiﬁed
morphologically as non-calciﬁed, spotty calciﬁcations or dense
calciﬁcations. Non-calciﬁed plaques were deﬁned as a plaque
with low CT attenuation located in the vessel wall in at least
two independent image planes and clearly distinguishable from
the contrast-enhanced lumen and pericardial tissue without any
calciﬁcation.
17 Plaques with spotty calciﬁcations were deﬁned
as follows: length (extent in the longitudinal direction of the
vessel) of the calciﬁcation\3/2 of vessel diameter and width
(extent of the calciﬁcation perpendicular to the longitudinal
direction of the vessel) of the calciﬁcation \2/3 of vessel
diameter, as previously described (Figure 1).
17 Plaques with
spotty calciﬁcation were further differentiated according to
their length (extent of the calciﬁcation parallel to the longitu-
dinal direction of the vessel on curved multiplanar
reconstruction) into small spotty (\1 mm), intermediate spotty
(1-3 mm), and large spotty calciﬁcations (C3 mm) as mea-
sured with caliper function (for illustration see Figure 2).
18
Dense calciﬁcations were deﬁned as a plaque with high CT
density, completely calciﬁed and with calciﬁcations present
bilateral on cross-sectional axial slices.
Invasive IVUS-VH
Image acquisition. Conventional invasive coro-
nary angiography was performed according to standard
protocols. IVUS examinations were acquired with a 20 MHz,
2.9 F phased-array IVUS catheter, (Eagle Eye, Volcano Cor-
poration, Rancho Cordova, CA, USA) and a dedicated IVUS-
console (Volcano Corporation, Rancho Cordova, CA, USA)
after intracoronary administration of nitroglycerine. Under
ﬂuoroscopic guidance, the IVUS catheter was introduced dis-
tally in the coronary artery and a motorized automated
pullback with a continuous speed of 0.5 mm/second was used
until the catheter reached the guiding catheter. Images were
stored on CD-ROM or DVD for off-line analysis.
Image analysis. IVUS-VH analysis was performed
by two experienced observers blinded to baseline patient
characteristics and CTA ﬁndings with the use of dedicated
software (QCU-CMS, version 4.59, Medis Medical Imaging
Systems, Leiden, the Netherlands). First, contour detection
(lumen and media interface) was performed manually with the
use of cross-sectional views to provide compositional output.
19
Secondly, on a frame-by-frame basis, the four different tissue
components were differentiated and labeled with four different
color-codes (ﬁbrotic tissue was labeled in dark green, ﬁbro-
fatty tissue in light green, necrotic core in red and dense cal-
cium in white), as validated previously.
10 The mean percentage
of each plaque component was obtained in the full length of
the lesion observed on the CTA examination. A lesion on
intravascular ultrasound imaging was deﬁned as at least three
consecutive frames with a plaque burden of at least 40%.
20 In
addition, the presence of the thin cap ﬁbroatheroma (TCFA)
Figure 1. Example of measurement of spotty calciﬁcation. Plaques with spotty calciﬁcations were
deﬁned as follows: length (extent in the longitudinal direction of the vessel) of the calciﬁcation
\3/2 of vessel diameter and width (extent of the calciﬁcation perpendicular to the longitudinal
direction of the vessel) of the calciﬁcation \2/3 of vessel diameter. A, Measurement of vessel
diameter (blue line) perpendicular to long vessel axis (dashed white line). B, Measurement of length
of calciﬁcation (blue line) parallel to long vessel axis (dashed white line). C, Measurement of width
of calciﬁcation (blue line) perpendicular to long vessel axis (dashed line).
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lesion with a plaque burden C40%, presence of [10% con-
ﬂuent necrotic core on three consecutive frames and necrotic
core in contact with the lumen for along the lumen cir-
cumference.
14,21,22 High-risk plaque characteristics on IVUS-
VH were deﬁned by % of necrotic core and presence of
TCFA.
To ensure that identical plaques were assessed by CTA
and IVUS-VH, coronary ostia and side branches were used as
landmarks and distances from the landmarks to the target
lesions were measured (Figure 3). On CTA, distances were
measured using multiplanar reconstructions. On IVUS-VH,
longitudinal reconstructed ECG triggered datasets were used to
measure the difference between corresponding plaque and
landmarks. After alignment of plaques on CTA and IVUS-VH,
we identiﬁed matching slices between the two modalities and
could determine the proximal and distal end of a lesion.
Examples of different calciﬁcation patterns on CTA with
corresponding IVUS-VH images are demonstrated in Figures 4
and 5.
Statistical analysis. Plaques available on both
CTA and IVUS-VH were included in the lesion based analysis.
Plaque composition (% ﬁbrotic, ﬁbro-fatty, necrotic core, and
dense calcium) and presence of TCFA was compared between
lesions with different calciﬁcation patterns on CTA (non-cal-
ciﬁed, small spotty calciﬁcations, intermediate spotty
calciﬁcations, large spotty calciﬁcations, and dense calciﬁca-
tions). If normally distributed, continuous values were
expressed as means (±standard deviation) and differences in
plaque composition and type were assessed using an analysis
of variance (ANOVA). If not normally distributed, values
were expressed as medians (interquartile range (IQR)) and
differences in plaque composition and type were assessed
using the Kruskall-Wallis test. To account for possible clus-
tering of coronary artery plaques within patients, the
generalized estimating equation (GEE) method was applied to
evaluate the differences in plaque characteristics between
the groups of different calciﬁcation patterns on CTA (non-
calciﬁed, small spotty calciﬁcations, intermediate spotty cal-
ciﬁcations, large spotty calciﬁcations, and dense calcium). This
was performed with proc GENMOD with a binominal distri-
bution for the outcome variable, the link function speciﬁed as a
logistical (presence of TCFA) or a linear (% ﬁbrotic, ﬁbro-
fatty, necrotic core, and dense calcium) distribution and
patients as separate subjects. Due to lack of power, we did not
perform post-hoc analysis. A P value of\.05 was considered
statistically signiﬁcant. Statistical analysis was performed
using SPSS 17.0 software (SPSS Inc., Chicago. Illinois).
RESULTS
Out of a total of 108 patients, 33 patients (31%)
were scanned with a 64-row CTA scanner and 75
patients (69%) with a 320-row CTA scanner. Baseline
patient characteristics are provided in Table 1. In sum-
mary, 80 patients (74%) were male and mean age was
57 ± 10 years. IVUS-VH examination was successfully
performed in 264 vessels (81%) of the available 324
vessels without complications (right coronary artery
(RCA), n = 88; left anterior descending coronary artery
(LAD), n = 98; left circumﬂex coronary artery (LCx),
n = 78). In the remaining vessels, IVUS imaging could
Figure 2. Illustration of the different types of spotty calciﬁcation. A, Small spotty calciﬁcation
(\1 mm). B, Intermediate spotty calciﬁcation (1-3 mm). C, Large spotty calciﬁcation ([3 mm).
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stenosis, vessel occlusion or due to time-constraints in
the cathlab.
Baseline CTA and IVUS-VH Results
In total, 799 plaques were demonstrated on CTA
and in 300 plaques (38%) IVUS-VH was also available.
Figure 3. Example of anatomical matching of computed tomography angiography (CTA) with
intravascular ultrasound with radiofrequency backscatter analysis (IVUS-VH) datasets. A,
Straightened multiplanar reconstruction of left anterior descending coronary artery in which
various landmarks have been identiﬁed (left circumﬂex artery (LCx), ﬁrst and second diagonal
branch (D1 and D2). B and C, Corresponding grayscale intravascular ultrasound and IVUS-VH
datasets in longitudinal view in which identical landmarks have been matched to CTA dataset
(yellow dashed line). Corresponding cross-sectional view of minimal lumen area on CTA (D) and
IVUS-VH (E, F).
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Volume 18, Number 5;893–903 Calciﬁcation patterns on CTAOf the 300 plaques identiﬁed on CTA, 78 plaques (26%)
were non-calciﬁed, 39 plaques (13%) had small spotty
calciﬁcations (\1 mm), 96 plaques (32%) had interme-
diate spotty calciﬁcations (1-3 mm), 54 plaques (18%)
had large spotty calciﬁcations (C3 mm), and 33 plaques
(11%) had dense calciﬁcations. On IVUS-VH, the
average plaque length analyzed was 26 ± 18 mm. The
most prevalent plaque component was ﬁbrotic tissue
(58%, IQR 50%-63%), followed by necrotic core (15%,
IQR 10%-21%), ﬁbro-fatty tissue (13%, IQR 8%-21%),
and dense calcium (6%, IQR 3%-10%). Visual plaque
assessment revealed that 52 plaques (17%) were clas-
siﬁed as TCFA.
Comparison of Calciﬁcation Patterns
on CTA and Plaque Composition
on IVUS-VH
The results comparing calciﬁcation patterns on
CTA against relative plaque composition on IVUS-VH
are reported in Table 2. Small spotty calciﬁcations
contained less ﬁbro-fatty tissue (9%, IQR 6%-15%) as
compared to non-calciﬁed plaques (12%, IQR 8%-22%),
intermediate spotty calciﬁcations (13%, IQR 7%21%),
large spotty calciﬁcations (15%, IQR 9%-25%), and
dense calciﬁcations (20%, IQR 13%-25%, P\.05). In
line with this observation, the more calciﬁed plaques
Figure 4. Example of small spotty calciﬁcations as assessed on computed tomography angiog-
raphy (CTA) with high-risk plaque characteristics on intravascular ultrasound with radiofrequency
backscatter analysis (IVUS-VH). A, Multiplanar reconstruction of the right coronary artery (RCA)
demonstrating a plaque with non-calciﬁed elements and spotty calciﬁcations (arrow). B,
Enlargement of the same plaque demonstrating a spotty calciﬁcation with a length of 0.7 mm.
C, Longitudinal reconstructed ECG triggered IVUS-VH run with superimposed color coded map.
The plaque (white arrow) corresponds to the same plaque on CTA demonstrating a large necrotic
core and multiple small spotty calciﬁcations. D, Cross-sectional axial image of the same plaque
demonstrating calciﬁcations (white) and a large necrotic core (red) indicating presence of a thin cap
ﬁbroatheroma (TCFA).
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VH than the non-calciﬁed plaques (9%, IQR 6%-11% vs
3%, IQR 1%-6%, P\.001). More importantly, necrotic
core was signiﬁcantly higher in plaques with small
spotty calciﬁcations (20%, IQR 12%-24%) as compared
to non-calciﬁed plaques (13%, IQR 6%-20%, P = .006).
Figure 5. Example of a plaque with dense calciﬁcations on computed tomography angiography
(CTA) with corresponding grayscale and intravascular ultrasound with radiofrequency backscatter
analysis (IVUS-VH) images. A, Curved multiplanar reconstruction of the right coronary artery
(RCA) demonstrating a plaque with dense calciﬁcations (arrow). Inlay showing cross-sectional
axial image of the same plaque with calciﬁcations present bilateral of the coronary artery. B,
Enlargement of the same plaque reporting the length of the calciﬁcation (4.5 mm). C, Grayscale
IVUS image demonstrating a heavily calciﬁed plaque with corresponding IVUS-VH image (D)
showing a plaque with heavy calciﬁcations (white).
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necrotic core in plaques with small spotty calciﬁcations
than in plaques with intermediate spotty calciﬁcations
(P = .053). Moreover, as demonstrated in Figure 6,
plaques with small spotty calciﬁcations were demon-
strated to have a high percentage of TCFA (31%) as
compared to large spotty calciﬁcations (9%) and dense
calciﬁcations (6%, P\.05). In addition, there was a
trend for plaques with small spotty calciﬁcations to have
a higher percentage of TCFA than plaques with inter-
mediate spotty calciﬁcations (17%, P = .073).
However, no signiﬁcant difference was demonstrated
between the percentage of TCFA in plaques with
small spotty calciﬁcations and non-calciﬁed plaques
(P = .37).
DISCUSSION
This study systematically evaluated the relation
between different calciﬁcation patterns on CTA and
plaque characteristics on invasive IVUS-VH. It was
demonstrated that plaques with spotty calciﬁcations, in
particular the smaller spotty calciﬁcations (\1 mm) had
plaque characteristics deemed high-risk on IVUS-VH, as
deﬁned by a higher % of necrotic core and presence of
TCFA.
Interestingly, the present ﬁndings are in line with
histopathological studies which have reported that
lesions associated with acute coronary events are often
not heavily calciﬁed.
20,21,23 Burke et al
21 studied the
degree of calciﬁcation in serial sections of coronary
arteries in sudden coronary death cases and observed
that plaque ruptures showed relatively little calciﬁcation
and that most acute plaque ruptures resulting in sudden
death occurred in areas of only mild speckled calciﬁ-
cation. Furthermore, smaller calcium deposits on
grayscale IVUS have been related to more unstable
clinical presentation such as unstable angina and myo-
cardial infarction. Beckman et al
24 measured the arc of
calcium in lesions of 78 patients and found that the
average arc of calcium was greatest (32 ±7 )i n
patients with stable angina, less (15 ±4 ) in patients
with unstable angina, and least (10 ±5 ) in patients
with acute myocardial infarction (P\.014). In line with
these ﬁndings, van der Hoeven et al
18 studied 60 patients
Table 1. Baseline patient characteristics
Number of patients 108
Age (years) 57 ± 10
Male gender 80 (74%)
Stable angina/suspected acute coronary
syndrome
38/70
Hypertension
  63 (58%)
Hypercholesterolemia
  55 (51%)
Diabetes 29 (27%)
Smoking 43 (40%)
Family history of CAD 49 (45%)
Obesity (C30 kg/m
2) 21 (19%)
Medication at time of referral
Aspirin 61 (57%)
Statins 69 (64%)
ACE inhibitor 53 (49%)
Beta-blockers 58 (54%)
Previous myocardial infarction 22 (20%)
Previous PCI 29 (27%)
Data are absolute values, percentages or means ± standard
deviation
CAD, Coronary artery disease; ACE, angiotensin-converting
enzyme; PCI, percutaneous coronary intervention
  Deﬁned as systolic blood pressure C140 mmHg or diastolic
blood pressure C90 mmHg or the use of antihypertensive
medication
  Serum total cholesterol C230 mg/dL or serum triglycerides
C200 mg/dL or treatment with lipid lowering drugs
Table 2. Plaque composition on intravascular ultrasound with radiofrequency backscatter analysis
(IVUS-VH) is reported in relation to the different calciﬁcation patterns on computed tomography
angiography (CTA)
Non-
calciﬁed
Small
spotty
(<1 mm)
Intermediate
spotty
(1-3 mm)
Large
spotty
(‡3 mm)
Dense
calciﬁcations
Global
P value
% Fibrotic 61 (55–68) 56 (50–63) 58 (50–64) 54 (49–59) 54 (49–59) \.001
% Fibro-fatty 12 (8–22)* 9 (6–15) 13 (7–21)* 15 (9–25)* 20 (13–25)* \.001
% Necrotic core 13 (6–20)* 20 (12–24) 14 (9–21)** 17 (13–21) 14 (12–22) .003
% Dense calcium 3 (1–6)* 7 (4–13) 6 (3–10) 9 (6–13) 9 (6–11) \.001
Data in parentheses are percentages with 95% conﬁdence intervals
* P value\.05, individual groups compared to plaques with small spotty calciﬁcations as reference group
** P value = .053, individual group compared to plaques with small spotty calciﬁcations as reference group
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demonstrated that small calciﬁed spots (arc\45, length
\1.5 mm) were more common in the culprit lesions as
compared to the adjacent distal and proximal segments.
Accordingly, Ehara et al
25 conﬁrmed the ﬁndings in a
larger patient population of 178 patients with grayscale
IVUS. The authors found that not only the frequency of
calcium deposits was signiﬁcantly different between
patients with stable, unstable angina, and myocardial
infarction but also calcium deposits were signiﬁcantly
longer in patients with stable angina (mean length of
4.3 ± 3.2 mm) as compared to patients with unstable
angina (mean length of 1.9 ± 1.8) and myocardial
infarction (mean length of 2.2 ± 1.6). Thus, these ﬁnd-
ings support the concept that there may be a signiﬁcant
difference in the pattern of coronary calciﬁcations,
particularly with respect to size and length of the
deposits, among patients with stable and unstable
angina.
Non-invasively, calcium scoring with electron beam
computed tomography (EBCT) showed similar ﬁndings.
Althoughahighercalciumscorehasbeenrelatedtolarger
plaque areas and worse prognosis,
26 when comparing
coronary calcium scores of patients with stable angina to
patients with acute myocardial infarction, signiﬁcant
differenceswereobserved.
27Extensivecalciumwasmore
often present in the coronary arteries of patients with
chronic stable angina, whereas patients with acute myo-
cardial infarction demonstrated a more diffuse pattern
of calciﬁcations. More interestingly, using contrast-
enhanced CTA, the presence of spotty calciﬁcations were
frequently present in lesions of patients with ACS but
rarely observed in culprit lesions of patients with stable
CAD.
9 Similarly, Motoyama et al
7,8 demonstrated both
retrospectively and prospectively with CTA that non-
calciﬁed plaques with spotty calciﬁcations and positive
remodeling were associated with a higher likelihood of
the development of ACS. However, unlike this study, the
aforementioned ﬁndings were not related to invasive
observations. Interestingly, a previous study by our
institution evaluated the association between plaque
composition on CTA and the presence of high-risk fea-
tures on IVUS-VH in a smaller population of 50
patients.
28 It was demonstrated that the more high-risk
plaques (TCFA) were most often present in mixed pla-
ques (32%) on CTA. Although similar to the current
ﬁndings, the % of TCFA in mixed plaques was higher in
the previous evaluation than in the current study (31%).
Thiscouldprobablybeexplainedbydifferenceinthesize
and baseline characteristics of the patient population. In
addition,theamountofdensecalciuminthecurrentstudy
is somewhat lower than reported in other studies. How-
ever, this could be explained by the inclusion of a
substantial number (65%) of patients presenting with
acute coronary syndrome, known to have substantially
less calciﬁed arteries.
Interestingly, earlier investigations have used vari-
ous deﬁnitions of spotty calciﬁcations on CTA. For
instance, some investigations described spotty calciﬁ-
cation as any calciﬁed material embedded within a
non-calciﬁed plaque, whereas other use a threshold of
calciﬁed material less than 3 mm in size.
7,9,29 However,
a comprehensive approach for the evaluation of the
extent of the spotty calciﬁcations on CTA is preferred,
thereby improving reproducibility and use in risk strati-
ﬁcation. The strength of the current study is that a
systematic approach for the evaluation of spotty calciﬁ-
cations was applied, demonstrating that indeed the
smaller spotty calciﬁcations were related to the plaque
characteristics deemed more high-risk such as necrotic
core and presence of TCFA.
Importantly, the ﬁndings are clinically relevant
considering that CTA is increasingly used for the
assessment of CAD and the use of this technique is
extended from assessment of stenosis to the evaluation
of the vessel wall. Nevertheless, even with the latest
generation CTA scanners, exact identiﬁcation of the
lipid core and thin ﬁbrous cap is not feasible at the
moment. Therefore, assessment of spotty calciﬁcation
on CTA may be beneﬁcial for individualized risk strat-
iﬁcation in combination with other high-risk features
such as cardiovascular risk factors and biomarkers.
Perhaps, CTA has a potential application in the context
Figure 6. Bar graph represents the percentage of thin cap
ﬁbroatheroma (TCFA) in relation to the different calciﬁcation
patterns on computed tomography angiography (CTA). As is
shown, in particular plaques with small spotty calciﬁcations on
CTA contain the highest percentage of TCFA as compared to
large spotty calciﬁcations and dense calcium. *Small spotty
calciﬁcations did not have more TCFA than non-calciﬁed
plaques (P = ns).
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However, the clinical and prognostic impact of these
ﬁndings has to be evaluated in future prospective
studies.
LIMITATIONS
First, due to the limitations of intravascular ultra-
sound, not all plaques on CTA were also evaluated by
IVUS-VH. In addition, detection of the thin ﬁbrous cap
(\65 lm) is not yet feasible as IVUS-VH has a limited
radial resolution of only 100 lm. Furthermore, it has
been suggested that dense calcium on IVUS-VH is
related to artifacts in the form of a halo of necrotic core
surrounding dense calcium. However, no standard-
ized method for correcting for this issue is currently
available. Additionally, no other high risk plaque
characteristics were assessed on CTA. Potentially,
incorporating other CTA variables such as degree of
stenosis and overall plaque burden, may allow for better
risk stratiﬁcation. In addition, this study performed a
retrospective analysis of data possibly introducing a bias
with regards to lesion selection. Future evaluations
examining on the relationship between calciﬁcation
patterns on CTA and IVUS-VH characteristics should be
performed in a more prospective manner. Moreover,
reproducibility information on the measurement of cal-
ciﬁcation on CTA was not provided. Lastly, CTA is
inherently associated with radiation exposure. However,
recently, dose-saving algorithms and prospective ECG
triggering were introduced to substantially reduce radi-
ation dose.
30
CONCLUSION
The current study demonstrated that plaques with
small spotty calciﬁcations on CTA were related to pla-
que characteristics deemed more high-risk on invasive
IVUS-VH. Therefore, CTA may be valuable in the
assessment of the vulnerable plaque.
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